Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | $5.25B | $4.94B | $562.00M | $335.00M | $6.23 | 0.55% | 6.68% | 11.65% | 16.85% | ||
| NGNE | NEUROGENE INC | $432.37M | $0.00 | -$34.67M | -$39.03M | $31.76 | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $616.68M | $50.02M | -$77.74M | -$78.92M | -$1.81 | 25.70% | 54.65% | N/A | N/A | ||
| CPA | COPA HOLDINGS SA | $4.60B | $3.46B | $1.08B | $514.10M | $12.78 | 16.59% | 5.24% | 48.95% | 43.78% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.41B | $0.00 | -$208.53M | -$208.94M | -$2.51 | N/A | N/A | N/A | N/A | ||
| GEF | GREIF INC | $3.01B | $5.15B | $749.30M | $336.50M | $5.84 | -14.91% | 5.92% | -24.55% | 13.43% | 2024-06-05 | |
| APTO | APTOSE BIOSCIENCES INC | $19.25M | $0.00 | -$46.73M | -$47.17M | -$6.20 | N/A | N/A | N/A | N/A | ||
| ANNX | ANNEXON INC | $400.15M | $0.00 | -$117.42M | -$120.74M | -$1.46 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| ACLS | AXCELIS TECHNOLOGIES INC | $3.68B | $1.13B | $303.78M | $250.16M | $7.64 | 16.34% | 22.34% | 32.87% | 45.29% | ||
| DNTH | DIANTHUS THERAPEUTICS INC | $752.23M | $2.26M | -$43.10M | -$42.36M | $3.83 | -20.15% | N/A | N/A | N/A | 2024-05-23 | |
| APGE | APOGEE THERAPEUTICS INC | $2.94B | $0.00 | -$103.17M | -$103.55M | -$5.25 | N/A | N/A | N/A | N/A | ||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.72B | $0.00 | -$239.53M | -$240.63M | -$3.23 | N/A | -100.00% | N/A | N/A | ||
| RRX | REGAL REXNORD CORP | $10.62B | $6.57B | $1.05B | -$31.70M | -$0.48 | 27.82% | 12.67% | N/A | N/A | ||
| IMVT | IMMUNOVANT INC | $4.46B | $0.00 | -$242.72M | -$243.45M | -$1.83 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.